MedTrace Logo

COPD Exacerbation Alert System With urinE anaLysis Using the HEADSTART Device

NCT04296318 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 86

Last updated 2022-07-28

No results posted yet for this study

Summary

The Headstart Test system is an in vitro diagnostic test intended for self-testing for the detection of five biomarkers of infection in the urine of patients diagnosed with chronic obstructive pulmonary disease (COPD).

Patient urine testing will be conducted daily to establish a patient baseline biomarker profile and provide ongoing monitoring for changes in the biomarker profile. Headstart results will be used as an aid in monitoring and early detection of pulmonary exacerbation.

Conditions

  • COPD Exacerbation

Sponsors & Collaborators

  • University Hospitals, Leicester

    collaborator OTHER

  • Mologic Ltd

    lead INDUSTRY

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-11-19
Primary Completion
2022-02-15
Completion
2022-07-24

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04296318 on ClinicalTrials.gov